ANK1 and HSPB1 |
ankyrin 1 |
heat shock protein family B (small) member 1 |
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- NrCAM interactions
- CHL1 interactions
- Neurofascin interactions
- Neurofascin interactions
- COPI-mediated anterograde transport
|
- VEGFA-VEGFR2 Pathway
- AUF1 (hnRNP D0) binds and destabilizes mRNA
- MAPK6/MAPK4 signaling
- Extra-nuclear estrogen signaling
|
|
- Apatorsen
- Phenethyl Isothiocyanate
|
- Hereditary spherocytosis (SPH)
|
- Distal hereditary motor neuropathies (dHMN)
|
ANK1 and RHAG |
ankyrin 1 |
Rh associated glycoprotein |
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- NrCAM interactions
- CHL1 interactions
- Neurofascin interactions
- Neurofascin interactions
- COPI-mediated anterograde transport
|
- Erythrocytes take up carbon dioxide and release oxygen
- Erythrocytes take up oxygen and release carbon dioxide
- Rhesus glycoproteins mediate ammonium transport.
- Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)
|
|
|
- Hereditary spherocytosis (SPH)
|
- Hereditary stomatocytosis (HSt); Dehydrated hereditary stomatocytosis (DHS); Overhydrated hereditary stomatocytosis (OHS); Familial pseudohyperkalemia (FP)
|
ANK1 and EPB42 |
ankyrin 1 |
erythrocyte membrane protein band 4.2 |
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- NrCAM interactions
- CHL1 interactions
- Neurofascin interactions
- Neurofascin interactions
- COPI-mediated anterograde transport
|
|
|
|
- Hereditary spherocytosis (SPH)
|
|
ANK1 and SLC4A1 |
ankyrin 1 |
solute carrier family 4 member 1 (Diego blood group) |
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- NrCAM interactions
- CHL1 interactions
- Neurofascin interactions
- Neurofascin interactions
- COPI-mediated anterograde transport
|
- Erythrocytes take up carbon dioxide and release oxygen
- Erythrocytes take up oxygen and release carbon dioxide
- Bicarbonate transporters
- Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)
|
|
|
- Hereditary spherocytosis (SPH)
|
- Hereditary elliptocytosis (HE)
- Hereditary spherocytosis (SPH)
- Hereditary stomatocytosis (HSt); Dehydrated hereditary stomatocytosis (DHS); Overhydrated hereditary stomatocytosis (OHS); Familial pseudohyperkalemia (FP)
- Distal renal tubular acidosis (RTA type 1)
|
SLC25A6 and PRSS23 |
solute carrier family 25 member 6 |
serine protease 23 |
- Mitochondrial protein import
- Mitochondrial protein import
- Influenza Virus Induced Apoptosis
- Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
- Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
|
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
|
|
|
|
ANXA1 and TRPM7 |
annexin A1 |
transient receptor potential cation channel subfamily M member 7 |
- G alpha (q) signalling events
- G alpha (i) signalling events
- Formyl peptide receptors bind formyl peptides and many other ligands
- Smooth Muscle Contraction
- Interleukin-4 and Interleukin-13 signaling
|
|
- Amcinonide
- Hydrocortisone
- Dexamethasone
|
- Phosphoaminophosphonic Acid-Adenylate Ester
- 1,4-Dithiothreitol
|
|
|
ANXA2 and TERT |
annexin A2 |
telomerase reverse transcriptase |
- Smooth Muscle Contraction
- Neutrophil degranulation
- Dissolution of Fibrin Clot
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
- Telomere Extension By Telomerase
- Formation of the beta-catenin:TCF transactivating complex
|
|
- Zidovudine
- Grn163l
- Tertomotide
|
|
- Cri du chat syndrome; Cat cry syndrome; Chromosme 5p deletion syndrome
|
ANXA5 and FDFT1 |
annexin A5 |
farnesyl-diphosphate farnesyltransferase 1 |
|
- Cholesterol biosynthesis
- PPARA activates gene expression
- Activation of gene expression by SREBF (SREBP)
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and EED |
annexin A5 |
embryonic ectoderm development |
|
- PRC2 methylates histones and DNA
- Oxidative Stress Induced Senescence
- PKMTs methylate histone lysines
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Transcriptional Regulation by E2F6
- HCMV Early Events
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and LAMC3 |
annexin A5 |
laminin subunit gamma 3 |
|
- Laminin interactions
- Laminin interactions
- Non-integrin membrane-ECM interactions
- MET activates PTK2 signaling
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and ITGB5 |
annexin A5 |
integrin subunit beta 5 |
|
- Cross-presentation of particulate exogenous antigens (phagosomes)
- Molecules associated with elastic fibres
- Integrin cell surface interactions
- Integrin cell surface interactions
- Syndecan interactions
- Syndecan interactions
- ECM proteoglycans
- Smooth Muscle Contraction
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and TERF2IP |
annexin A5 |
TERF2 interacting protein |
|
- Recognition and association of DNA glycosylase with site containing an affected pyrimidine
- Cleavage of the damaged pyrimidine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Cleavage of the damaged purine
- Cleavage of the damaged purine
- Meiotic synapsis
- Packaging Of Telomere Ends
- Telomere Extension By Telomerase
- DNA Damage/Telomere Stress Induced Senescence
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and TINF2 |
annexin A5 |
TERF1 interacting nuclear factor 2 |
|
- Recognition and association of DNA glycosylase with site containing an affected pyrimidine
- Cleavage of the damaged pyrimidine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Cleavage of the damaged purine
- Cleavage of the damaged purine
- Meiotic synapsis
- Packaging Of Telomere Ends
- Telomere Extension By Telomerase
- DNA Damage/Telomere Stress Induced Senescence
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
- Revesz syndrome; Exudative retinopathy with bone marrow failure
|
ANXA5 and SUPT4H1 |
annexin A5 |
SPT4 homolog, DSIF elongation factor subunit |
|
- Formation of RNA Pol II elongation complex
- Formation of the Early Elongation Complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of the HIV-1 Early Elongation Complex
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Abortive elongation of HIV-1 transcript in the absence of Tat
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA polymerase II transcribes snRNA genes
- RNA Polymerase II Transcription Elongation
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and KDR |
annexin A5 |
kinase insert domain receptor |
|
- Neurophilin interactions with VEGF and VEGFR
- VEGF binds to VEGFR leading to receptor dimerization
- Integrin cell surface interactions
- VEGFA-VEGFR2 Pathway
- VEGFA-VEGFR2 Pathway
- VEGFR2 mediated cell proliferation
- Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
- Sorafenib
- Sunitinib
- N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA
- Cediranib
- Vatalanib
- XL999
- TG-100801
- XL820
- CYC116
- Ramucirumab
- ABT-869
- IMC-1C11
- Semaxanib
- Pazopanib
- Midostaurin
- Axitinib
- 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide
- N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide
- N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide
- 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide
- N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE
- N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE
- 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one
- 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one
- N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide
- N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
- N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
- Cabozantinib
- Regorafenib
- Ponatinib
- Lenvatinib
- Nintedanib
- Foretinib
|
|
|
ANXA5 and COL2A1 |
annexin A5 |
collagen type II alpha 1 chain |
|
- Collagen degradation
- Collagen degradation
- Extracellular matrix organization
- Collagen biosynthesis and modifying enzymes
- Signaling by PDGF
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Assembly of collagen fibrils and other multimeric structures
- Integrin cell surface interactions
- Integrin cell surface interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- ECM proteoglycans
- NCAM1 interactions
- MET activates PTK2 signaling
- Collagen chain trimerization
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
- Collagenase clostridium histolyticum
|
|
- Type II collagenopathies, including: Achondrogenesis II; Hypochondrogenesis; SED congenita; SMED Strudwick type; Kniest dysplasia; Spondyloperipheral dysplasia; Osteoarthritis with mild chondrodysplasia; Stickler syndrome 1; Platyspondylic skeletal dysplasia, Torrance type; Epiphyseal dysplasia, multiple, with myopia and deafness; Czech dysplasia
- Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
- Osteoarthritis with mild chondrodysplasia
|
ANXA5 and COL10A1 |
annexin A5 |
collagen type X alpha 1 chain |
|
- Collagen degradation
- Collagen degradation
- Collagen biosynthesis and modifying enzymes
- Assembly of collagen fibrils and other multimeric structures
- Integrin cell surface interactions
- Non-integrin membrane-ECM interactions
- Collagen chain trimerization
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
- Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
|
ANXA5 and APP |
annexin A5 |
amyloid beta precursor protein |
|
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Phenserine
- Tiomolibdate ion
- CAD106
- Mito-4509
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
|
|
|
ANXA5 and TERF1 |
annexin A5 |
telomeric repeat binding factor 1 |
|
- Recognition and association of DNA glycosylase with site containing an affected pyrimidine
- Cleavage of the damaged pyrimidine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Cleavage of the damaged purine
- Cleavage of the damaged purine
- Meiotic synapsis
- Packaging Of Telomere Ends
- Telomere Extension By Telomerase
- DNA Damage/Telomere Stress Induced Senescence
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|
ANXA5 and TERF2 |
annexin A5 |
telomeric repeat binding factor 2 |
|
- Recognition and association of DNA glycosylase with site containing an affected pyrimidine
- Cleavage of the damaged pyrimidine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Recognition and association of DNA glycosylase with site containing an affected purine
- Cleavage of the damaged purine
- Cleavage of the damaged purine
- Meiotic synapsis
- Packaging Of Telomere Ends
- Telomere Extension By Telomerase
- DNA Damage/Telomere Stress Induced Senescence
|
- L-Alpha-Glycerophosphorylserine
- L-thioproline
- K201
- L-Alpha-Glycerophosphorylethanolamine
- 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
- N,O6-Disulfo-Glucosamine
- 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
- Copper
|
|
|
|